3/5 NEUROCOGNITIVE AND NEUROIMAGING BIOMARKERS: PREDICTING PROGRESSION TOWARDS DEMENTIA IN PATIENTS WITH TREATMENT RESISTANT LATE-LIFE DEPRESSION